The Northern Ireland Sensory Ageing Study
NISA
1 other identifier
observational
842
1 country
1
Brief Summary
A visual function focused add-on study to the Northern Ireland Cohort for the Longitudinal Study of Ageing (NICOLA). There are three key aims:
- 1.Quantify age-related decline in a variety of visual functions within a populations based cohort.
- 2.Explore the mechanisms underlying age-related visual impairments.
- 3.Investigate how visual function impacts vision related quality of life.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Nov 2014
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
November 1, 2014
CompletedFirst Submitted
Initial submission to the registry
April 28, 2016
CompletedFirst Posted
Study publicly available on registry
June 2, 2016
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 30, 2018
CompletedStudy Completion
Last participant's last visit for all outcomes
December 31, 2018
CompletedAugust 13, 2019
August 1, 2019
3.5 years
April 28, 2016
August 12, 2019
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Rate of decline of visual function with age
24 months
Study Arms (2)
Group 1 - aged 20-90 years
25 participants from each decade from 20-90. Those from 50+ will be recruited from the NICOLA study and retinal/lens images assessed to confirm normality.
Group 2: aged 60 years
Group 2: 250 participants NICOLA participants aged 60 will be invited to participate; only those whose ocular images confirm normality will be included.
Eligibility Criteria
25 participants from each decade from 20-90. Those from 50+ will be recruited from the NICOLA study. 250 participants NICOLA participants aged 60 will be invited to participate; only those whose ocular images confirm normality will be included.
You may qualify if:
- No diagnosed ocular disease.
- Non-diabetic.
You may not qualify if:
- Any diagnosed ocular disease.
- Diabetic.
- Cognitive impairment.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Queen's University, Belfastlead
- College of Optometristscollaborator
Study Sites (1)
NI Clinical Research Facility
Belfast, Northern Ireland, BT9 7AB, United Kingdom
Biospecimen
Blood sample.
Study Officials
- PRINCIPAL INVESTIGATOR
Ruth Hogg
Queen's University, Belfast
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Doctor
Study Record Dates
First Submitted
April 28, 2016
First Posted
June 2, 2016
Study Start
November 1, 2014
Primary Completion
April 30, 2018
Study Completion
December 31, 2018
Last Updated
August 13, 2019
Record last verified: 2019-08
Data Sharing
- IPD Sharing
- Will not share